New Drug Delivery System Brings Hope to Mesothelioma Patients

by Shrader Law | Feb 12, 2013 | Mesothelioma

Scottish researchers at the University of Stratthclyde in Glasgow have recently found a new way of delivering chemotherapy to patients suffering from pleural mesothelioma and lung cancer. Mesothelioma is a rare and deadly disease that affects the mesothelium, or the lining of organs such as the lungs, abdominal organs, and heart. In the case of pleural mesothelioma, the disease affects the...

View Article

New Mesothelioma Orphan Drug Approved

by Shrader Law | Feb 12, 2013 | Mesothelioma

A new drug has recently become another treatment option for patients battling from malignant pleural mesothelioma. The drug, Amatuximab made by Morphotek, was recently granted orphan drug status by the FDA. A drug may be designated an orphan drug if it is used to treat fewer than 200,000 people in the U.S., thanks to the Orphan Drug Act. If a disease affects fewer than 200,000 people, it is...

View Article

Breath Test May Speed Mesothelioma Diagnosis

by Shrader Law | Feb 11, 2013 | Mesothelioma

Dutch researchers report that they might have developed a breath test that could be beneficial in diagnosing pleural mesothelioma. University of Amsterdam Medical Center researchers state that they can use a device called the Cyranose 320 to differentiate between healthy people, people with mesothelioma, and people who have had long-term asbestos exposure but do now show signs of mesothelioma....

View Article

Mesothelioma Warning Signs

by Shrader Law | Feb 10, 2013 | Mesothelioma

Mesothelioma is a very rare yet deadly type of cancer caused almost exclusively by exposure to asbestos. Mesothelioma is cancer that forms in the protective membrane that covers organs throughout the body, known as the mesothelium. The most common form of mesothelioma is pleural mesothelioma (of the lung), followed by peritoneal (abdominal) and pericardial (heart) mesothelioma. While anyone who...

View Article